NEWS
You can have a more comprehensive understanding of Sungening and gain insight into the industry's development trends through the latest information.
You can have a more comprehensive understanding of Sungening and gain insight into the industry's development trends through the latest information.
You can have a more comprehensive understanding of Sungening and gain insight into the industry's development trends through the latest information.
[Company Milestones] Sungening Biotechnology and Lizhu Pharmaceutical announce that the first patient to receive the Phase II clinical trial of the antifungal class 1 new drug SG1001 has been completed
View details[Good news for the company] Sungening Biotechnology has been honored as one of the "Top 100 New Enterprises in Longgang District" and its innovative strength has been recognized by authorities!
View details[Company Milestones] Good news! Sungening Biotech's innovative drug SG1001 has obtained FDA clinical trial approval, embarking on a global journey!
View details[Company milestone] Potential FIC! Sungening Biotech's Class 1 antifungal new drug SG1001 has completed Phase I clinical trials
View details2025 J.P.Morgan Week丨Sungening Biotechnology Innovation Project will debut in San Francisco
View detailsSungening Biotechnology won the first prize in the Longgang Innovation and Entrepreneurship Competition!
View detailsSungening Biotech's first innovative drug SG1001 successfully completed the first subject administration
View details
Insight into the development trend of the industry
A discovery to set your heart a-knocking
View detailsLaughter may be as effective as drops for dry eyes
View detailsGene therapy effective in hereditary blindness
View detailsDrugs prescribed off-label may do more harm than good
View detailsA discovery to set your heart a-knocking
View detailsCommon salt activates anti-tumor cells
View detailsGame-changing needle-free COVID-19 intranasal vaccine
View details
For better presentation, please browse vertically on the mobile end